Publications

Research & Development

• Clinical Programs

  Second Generation CDK Inhibitor
  • Fadraciclib (CYC065)
  DNA Damage Response
  • Sapacitabine (CYC682)
  Mitosis Regulation Program:
  • CYC140
• Other programs
• Science and Technology
  • Cell Cycle in Cancer
• Clinical Trials
• Publications